Stories like this do you make you wonder if CFU is doing enough to actually lock in whatever first-mover advantages they may have as the industry battle to become the dominant standard plays out.
The best technology doesn't guarantee success. Not sure I would be pushing to charge premium prices, even at this early stage of the S-Curve re the BlueGen product life cycle. Maximising the return to the company is important but so is actually gaining market share.
Last year's Annual Report said the main focus for the next 12 months was generating Sales, so where are these Sales?
CFU Price at posting:
12.7¢ Sentiment: Buy Disclosure: Held
